| Literature DB >> 25196378 |
Alba Pérez-Perarnau1, Sara Preciado, Claudia Mariela Palmeri, Cristina Moncunill-Massaguer, Daniel Iglesias-Serret, Diana M González-Gironès, Miriam Miguel, Satoki Karasawa, Satoshi Sakamoto, Ana M Cosialls, Camila Rubio-Patiño, José Saura-Esteller, Rosario Ramón, Laia Caja, Isabel Fabregat, Gabriel Pons, Hiroshi Handa, Fernando Albericio, Joan Gil, Rodolfo Lavilla.
Abstract
A new class of small molecules, with an unprecedented trifluorothiazoline scaffold, were synthesized and their pro-apoptotic activity was evaluated. With an EC50 in the low micromolar range, these compounds proved to be potent inducers of apoptosis in a broad spectrum of tumor cell lines, regardless of the functional status of p53. Fast structure-activity relationship studies allowed the preparation of the strongest apoptosis-inducing candidate. Using a high performance affinity purification approach, we identified prohibitins 1 and 2, key proteins involved in the maintenance of cell viability, as the targets for these compounds.Entities:
Keywords: antitumor agents; drug discovery; fluorine; heterocycles; medicinal chemistry
Mesh:
Substances:
Year: 2014 PMID: 25196378 DOI: 10.1002/anie.201405758
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336